The world’s second largest drug manufacturer, GlaxoSmithKline, will pay nearly $64 million to settle claims from parents of minor patients who were taking antidepressant drug Paxil.
The plaintiffs claim that the company provided misleading information about giving Paxil to minors, not adequately warning about possible suicidal side effects and withdrawal symptoms.
“The settlement was agreed upon to resolve the pending litigation and avoid further expenses,” Glaxo spokeswoman Mary Anne Rhyne said. “There was no liability admission.”
Glaxo is the target of more than 4,000 lawsuits, combined in a federal court in Los Angeles, that allege Paxil users suffered withdrawal symptoms. The company also faces suits in Pennsylvania and Texas state courts.
If you or someone you know has been injured as a result of taking a defective drug, it may be wise to consult an attorney to discuss your rights. Click on the form to the right for a free case evaluation.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.